Rheonova wishes you happy new year 2022!this past year have been rich, challenging and exciting, here is a small preview!
Happy New Year 2022!
read more
News
Rheomuco CE marking funding
Rheonova is supported by the Auvergne Rhône-Alpes region to ensure compliance with the new European regulation for CE marking of our medical device Rheomuco and the associated quality management system. The region, in collaboration with the Agency, Lyonbiopole and...
Rheonova granted the first regional PSPC
We are happy to announce that Rheonova, in collaboration with Cedrat Technologies and the laboratories TIMA and LRP, have been granted the regional PSPC for the project MucoPiezoRheo. This project aims to develop a medical device for personalized diagnosis and...
RheoCare project has received funding from the EU’s H2020 programme
Rheonova is proud to announce that the RheoCare project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 889360. The aim is to implement an automated sample manipulation device on the Rheomuco....
Meet us at the NACFS in Nashville from October 31 to November 2, 2019
North American Cystic Fibrosis Conference will stand in few days. Rheonova team would be glad to meet you there and present its Poster n°529 “RHEOLOGICAL SIGNATURE OF INDUCTION ON CF SPUTUM: SPONTANEOUS VERSUS HYPERTONIC SALINE VERSUS RHDNASE”
Pioneer in the chronic respiratory diseases sector, Rheonova opens its capital
Following Rheomuco's first sales to research laboratories in Europe, Rheonova wishes to boost its commercial activity. And to bring Rheomuco to the patient's bedside, 2 new clinical trials are underway. The first at Cochin Hospital for patients with cystic fibrosis...
13 European companies selected under EIT Health Go Global program to reach canadian market and healthtech innovation hubs
Following an intensive selection process through a dedicated European-Canadian jury, thirteen European companies are laureates of the 2019 edition of the GoGlobal Canada program and will benefit from a unique gateway to Canada. Click here for the full press release
Rheonova among the “Concours Innovation” winners
Winner of the "Concours Innovation", Rheonova will continue the clinical validation for a diagnostic test for Cystic Fibrosis. A financial aid of 352.000 € for the MucoCF project using the medical device Rheomuco® For the press release, click here
Rheonova and the Laboratory for Rheology & Process create «MUCUS».
Rheonova and the French Laboratory for Rheology & Process are proud to present the LabCom «MUCUS», a joint laboratory focused on new diagnostic and monitoring strategies for chronic pulmonary diseases. A 300K€ funding to sustain research partnership between...